FDA Investigator Bichsa T Nguyen
Bichsa T Nguyen has inspections in 1 countries as of 14 Sep 2023. Bichsa T Nguyen has collaborated with a combinined 2240 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amalia C Himaya,
Amalia Himaya,
Anastasia M Shields,
Angele C Smith,
Anita Narula, PhD,
Anthony G Emerson,
April P Shaw,
Barbara J Rincon,
Barry Cherney, PhD,
Bichsa T Tran,
Binh T Nguyen,
Bo Chi, PhD,
Brien C Fox,
Bryan A Galvez,
Carla J Lundi,
Carr Sharpe,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cheron M Portee,
Christina V Santos,
Claudia Mperez Kasmarski,
Daniel W Cline,
Davinna Ligons, PhD,
Deborah A Greco,
Dejon N Harris,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Dr. Monica D Cooper,
Frances Namuswe, PhD,
Frederick Fricke,
Frederick L Fricke,
Haley H Seymour,
Haley Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joe X Phillips,
Joel D Hustedt,
Joel Welch, PhD,
Joey V Quitania,
John A Gonzalez,
John R Myung,
Jolanna A Norton,
Joseph X Philips,
Julia Ventura,
Jun Park, PhD,
Ka L Wong,
Karen A Wolnik,
Kari M Johansen,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kham Phommachanh,
Kim Lthomas Cruse,
Lakecha N Lewis,
Laura Fontan, MS,
Lee,
Leonard H Lavi,
Liming Zhang,
Linda Thai,
Loretta J Jordan,
Mai X Huynh,
Marcia Britt Williams,
Marcus F Yambot,
Marie Falcone,
Marie T Falcone,
Mark C Saale,
Maurice M Sheehan,
Maxyne T Lam,
Michael D Garcia,
Michelle A Marsh,
Michsa T Nguyen,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Nelly N Tran,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Paul A Bonneau,
Peter C Chow,
Peter S Diak,
Rebecca Rodriguez,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Ronald L Koller,
Ronda Lebland,
Sandra A Boyd,
Sarah Arden,
Scott R Nichols, PhD,
Sidney B Priesmeyer,
Sonia R Peterson,
Stanley Au,
Steven E Porter, Jr,
Steven Fong, MS, PhD,
Sue Lee Chan,
Taichun Qin, PhD,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thomas R Beilke,
Tony J Wu,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Tuan A Nguyen,
Uttaniti Limchumroon (Tom),
Valerie L Whipp,
Virgilio F Pacio, CSO,
Walden H Lee,
Walden Lee,
William J Leonard,
Yasamin Ameri,
Yumi J Hiramine,
Yvette E Guillermo,
Yvonne C Wilkes,
Zachary A Bogorad
Bichsa T Nguyen's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2003 | FDA 483 | Med-Pharmex, Inc - Form 483, 2003-09-12 |
February, 2004 | EIR | Defender SD Manufacturing LLC - EIR, 2004-02-24 |
July, 2004 | EIR | La Jolla Pharmaceutical Co. - EIR, 2004-07-23 |
December, 2003 | FDA 483 Response | Amgen, Inc - Form 483R, 2004-01-06 |
February, 2004 | FDA 483 | Defender SD Manufacturing LLC - Form 483, 2004-02-24 |
July, 2004 | FDA 483 | La Jolla Pharmaceutical Co. - Form 483, 2004-07-23 |
December, 2003 | EIR | Amgen, Inc - EIR, 2003-12-12 |
December, 2003 | FDA 483 | Amgen, Inc - Form 483, 2003-12-12 |
May, 2004 | FDA 483 | Watson Laboratories, Inc. - Form 483, 2004-05-06 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more